Talking Tumors: Weill Cornell Medicine Experts Walk Through Challenging Breast Cancer Cases

Lisa Newman, MD, MPH, FACS, FASCO, and Alan B. Astrow, MD, discuss the need for systemic therapy in women with microinvasive triple-negative breast cancer and more intensive adjuvant therapy in women with intermediate-risk hormone receptor-positive, HER2-negative breast cancer.

Read the full article here

Related Articles